Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches ; volume:14 ; number:1 ; day:11 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (11.9.2024), 1-11, 12.2024
- Urheber
-
Kim, Yong-Hoon
Her, Ae-Young
Ko, Young-Guk
Ahn, Chul-Min
Lee, Seung-Jun
Hong, Myeong-Ki
Yu, Cheol Woong
Lee, Jae-Hwan
Lee, Seung Whan
Youn, Young Jin
Yoon, Chang-Hwan
Rha, Seung-Woon
Min, Pil-Ki
Choi, Seung-Hyuk
Chae, In-Ho
Choi, Donghoon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-71745-0
- URN
-
urn:nbn:de:101:1-2411252102511.995673813959
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Yong-Hoon
- Her, Ae-Young
- Ko, Young-Guk
- Ahn, Chul-Min
- Lee, Seung-Jun
- Hong, Myeong-Ki
- Yu, Cheol Woong
- Lee, Jae-Hwan
- Lee, Seung Whan
- Youn, Young Jin
- Yoon, Chang-Hwan
- Rha, Seung-Woon
- Min, Pil-Ki
- Choi, Seung-Hyuk
- Chae, In-Ho
- Choi, Donghoon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Combined Treatment of Native Femoropopliteal Occlusions in Chronic Limb-Threatening Ischemia Using Atherectomy Debulking and a New Sirolimus Drug-Coated Balloon (SELUTION SLR)
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
BioMimics 3D stent in femoropopliteal lesions: 3-year outcomes with propensity matching for drug-coated balloons
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-Coated Balloons for Restenosis Prophylaxis
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Combined Treatment of Native Femoropopliteal Occlusions in Chronic Limb-Threatening Ischemia Using Atherectomy Debulking and a New Sirolimus Drug-Coated Balloon (SELUTION SLR)
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
BioMimics 3D stent in femoropopliteal lesions: 3-year outcomes with propensity matching for drug-coated balloons
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-Coated Balloons for Restenosis Prophylaxis
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention
Combined Treatment of Native Femoropopliteal Occlusions in Chronic Limb-Threatening Ischemia Using Atherectomy Debulking and a New Sirolimus Drug-Coated Balloon (SELUTION SLR)
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Drug-coated balloon treatment for femoropopliteal artery disease : : the IN.PACT global study long lesion imaging cohort
Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
BioMimics 3D stent in femoropopliteal lesions: 3-year outcomes with propensity matching for drug-coated balloons
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-Coated Balloons for Restenosis Prophylaxis